Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–328 of 328 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Fetal Complications Clear all

Conditions: Infant, Premature, Diseases, Infant, Newborn, Diseases, Bronchopulmonary Dysplasia, Respiratory Distress Syndrome, Newborn, Meconium Aspiration Syndrome, Transient Tachypnea of the Newborn
Interventions: Non-invasive forced airway oscillometry; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 2 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Depression, Postpartum
Interventions: EIAU, LICF, HICF; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Mortality in Sickle Cell, Sickle Cell Cardiopulmonary Complications, Sickle Cell Organ Damage, Sickle Cell Life Expectancy and Risk Factors for Early Death, Sickle Cell Lung Disease and Sudden Death
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2035
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Preeclampsia, Fetal Growth Restriction
Interventions: Not listed
Lead sponsor: Fetal Medicine Foundation; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Dayton, Ohio

Conditions: Acute Blood Loss Anemia, Postoperative Pain, Pregnancy
Interventions: non-dissection of inferior rectus sheath, control; Procedure
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Fetal Hypoxia, Fetal Distress, Fetal Acidemia, Fetal or Neonatal Effect of Complication of Labor
Interventions: Dual fetal oxygen sensors; Device
Lead sponsor: Raydiant Oximetry, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Fetal Alcohol Spectrum Disorders
Interventions: My Health Coach; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Rochester, New York

Conditions: GDM, Preterm Preeclampsia, Preeclampsia, Fetal Growth Restriction (FGR), Pregnancy Complications
Interventions: None (this is an observational study with no intervention); Other
Lead sponsor: Medicines360; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 5,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Bridgeport, Connecticut • New Haven, Connecticut • Baton Rouge, Louisiana + 2 more

Conditions: Fetal Alcohol Spectrum Disorders, Fetal Alcohol Syndrome (FAS), Alcohol Related Neurodevelopmental Disorder, Alcohol Use Complicating Pregnancy, Unspecified Trimester
Interventions: Positive FASD education brochure, Negative FASD education brochure, Active comparator (a general women's health brochure); Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 422 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Fetal Alcohol Syndrome, Substance Abuse
Interventions: Brief motivational intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 612 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Miscarriage, Stillbirth, Cholera
Interventions: Shanchol; Biological
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 15 Years to 49 Years · Female only
Enrollment: 2,758 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Fetal Alcohol Spectrum Disorders
Interventions: Not listed
Lead sponsor: CAMC Health System; Other
Eligibility: Not listed
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Fetal Alcohol Spectrum Disorders, Fetal Alcohol Syndrome, Partial Fetal Alcohol Syndrome, Alcohol-related Neurodevelopmental Disorder, Prenatal Alcohol Exposure
Interventions: Choline, placebo supplementation consisting of vegetable glycerin (50% by volume) and deionized water; Dietary Supplement
Lead sponsor: San Diego State University; Other
Eligibility: 5 Years to 10 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Diego, California

Conditions: Intrauterine Growth Retardation
Interventions: selective laser photocoagulation of communicating vessels, Expected Management; Procedure · Device
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Los Angeles, California • Tampa, Florida

Conditions: Multicystic Dysplastic Kidney, Polycystic Kidney Disease, Fetal Renal Anomaly, Anhydramnios, Potter Syndrome, Lung Hypoplasia, Multicystic Renal Dysplasia, Bilateral, Lower Urinary Tract Obstructive Syndrome, Bilateral Renal Agenesis
Interventions: Amnioinfusion; Other
Lead sponsor: Fetal Care Center, PLLC; Industry
Eligibility: Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Assessment of Fetal Movement, Pregnancy, Pregnancy Complications, Pregnancy Complications Affecting Fetus (Diagnosis), Stillbirth, Stillbirth and Neonatal Mortality, Fetal Movement
Interventions: Smartphone Application; Device
Lead sponsor: Kenneth Moise MD; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Austin, Texas • Galveston, Texas • Houston, Texas

Search by objective public record fields.

Pulmonary Function Using Non-invasive Forced Oscillometry

Minimum Intervention to Maintain a Postpartum Depression Prevention Program in Clinics Serving Low-income Women

Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies

First Trimester Prediction of Preeclampsia and Fetal Growth Restriction

Effect of Non-Dissection of the Inferior Rectus Sheath on Intraoperative Blood Loss

Trans-abdominal Fetal Pulse Oximetry

Feasibility Study of the My Health Coach App for Adults With FASD

Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study

Development of Education Materials for Prevention of FAS in Russia

Fetal Alcohol Damage Prevention Study

Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi

Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder

Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders

Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery

Amnioinfusion for Fetal Renal Failure

Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements